Early treatment response to piperacillin/tazobactam in patients with bloodstream infections caused by non-ESBL ampicillin/sulbactam-resistant Escherichia coli: a binational cohort study.
Journal Information
Full Title: Infection
Abbreviation: Infection
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Allergy and Immunology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Conflict of interestThe authors have no competing interests to declare that are relevant to the content of this article. Ethical approvalResearch was conducted in accordance with the Declaration of Helsinki and national and institutional standards. The study protocol was approved by the local ethics committees of both centres (approval number of the leading ethics committee “JUH” No. 2020-1957). Due to the retrospective nature of the study the need for informed consent was waved. Conflict of interest The authors have no competing interests to declare that are relevant to the content of this article."
"Funding Open Access funding enabled and organized by Projekt DEAL. Internal funding."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025